Clinical Trial Update: The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts [Phase 4]

View source ↗

Summary

This clinical trial compares the efficacy of intralesional bleomycin versus intralesional purified protein derivative for treating palmoplantar warts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Warts
• Verruca Plantaris

Drugs mentioned

• Bleomycin (bleomycin)
• Purified Protein Derivative (purified protein derivative)

Snippet

Sponsor: Assiut University | Conditions: Warts | Phase 4 | Status: UNKNOWN